ALDACTONE Side Effects

6801837-1 | Blood Creatinine Increased, Hyperkalaemia
on Jun 17, 2010 Female patient from FRANCE , 60 years of age, was diagnosed with primary hyperaldosteronism, hypertension and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, hyperkalaemia. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with APROVEL (75 Mg, 1x/day) (View Aprovel Review and Aprovel Label ), LYRICA (75 Mg, Unk) (View Lyrica Review and Lyrica Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ), KARDEGIC (75 Mg, Unk) (View Kardegic Review and Kardegic Label ), INIPOMP (20 Mg, Unk) (View Inipomp Review and Inipomp Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6794559-7 | Bladder Pain, Bladder Spasm, Calculus Urinary, Cystitis, Haematuria, Insomnia, Sleep Disorder
Patient was taking Aldactone (View Usage). Patient had the following side effects: bladder pain, bladder spasm, calculus urinary, cystitis, haematuria, insomnia, sleep disorder (What is sleep disorder?) on Jun 15, 2010 from FRANCE Additional patient health information: Female patient , 66 years of age, weighting 141.1 lb, was diagnosed with hypertension, hyperaldosteronism, asthma (What is asthma?) and. Aldactone dosage: 12.5 Mg, 1x/day (half A 25 Mg Tablet Per Day). During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), OROCAL VITAMIN D (View Orocal Vitamin D Review and Orocal Vitamin D Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), AIROMIR (View Airomir Review and Airomir Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6783879-8 | Electrocardiogram Qt Prolonged, Syncope, Ventricular Extrasystoles, Ventricular Tachycardia
Adverse event was reported on Jun 10, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 50 Mg, 1x/day) . Location: FRANCE , 85 years of age, After Aldactone was administered, patient had the following side effects: electrocardiogram qt prolonged, syncope, ventricular extrasystoles, ventricular tachycardia. During the same period patient was treated with HYDROXYZINE HCL (25 Mg, 3x/day) (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), ISORYTHM (125 Mg, Daily) (View Isorythm Review and Isorythm Label ), RISPERDAL (1 Mg, 1x/day) (View Risperdal Review and Risperdal Label ), CITALOPRAM HYDROBROMIDE (20 Mg, 1x/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (1 Mg, 1x/day) (View Lorazepam Review and Lorazepam Label ).

6779004-X | Electrocardiogram Qt Prolonged, Syncope, Ventricular Extrasystoles, Ventricular Tachycardia
on Jun 09, 2010 Female patient from FRANCE , 85 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, syncope, ventricular extrasystoles, ventricular tachycardia. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with ISORYTHM (125 Mg, 1x/day) (View Isorythm Review and Isorythm Label ), RISPERDAL (1 Mg, 1x/day) (View Risperdal Review and Risperdal Label ), CITALOPRAM HYDROBROMIDE (20 Mg, 1x/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ATARAX (25 Mg, 3x/day) (View Atarax Review and Atarax Label ), LORAZEPAM (1 Mg, 1x/day) (View Lorazepam Review and Lorazepam Label ).


6775384-X | Dermatitis Exfoliative, Eyelid Oedema, Rash Macular, Rash Pustular, Skin Exfoliation
on Jun 09, 2010 Male patient from FRANCE , 65 years of age, was treated with Aldactone (View Usage). Patient had the following side effects: dermatitis exfoliative, eyelid oedema, rash macular, rash pustular, skin exfoliation. Aldactone dosage: Unk. During the same period patient was treated with INSULATARD (Unk) (View Insulatard Review and Insulatard Label ), ALLOPURINOL (1 Df, 1x/day) (View Allopurinol Review and Allopurinol Label ), CHONDROSULF (Unk) (View Chondrosulf Review and Chondrosulf Label ), TAHOR (View Tahor Review and Tahor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ), DIFFU K (View Diffu K Review and Diffu K Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ). Patient was hospitalized.

6775383-8 | Cardiac Failure
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: cardiac failure on Jun 09, 2010 from FRANCE Additional patient health information: Female patient , 90 years of age, . Aldactone dosage: 75 Mg, 1x/day. During the same period patient was treated with ACTOS (30 Mg, 1x/day) (View Actos Review and Actos Label ), CARDENSIEL (2.5 Mg, Unk) (View Cardensiel Review and Cardensiel Label ), LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COVERSYL (Unk Mg, Unk) (View Coversyl Review and Coversyl Label ), AMAREL (2 Mg, Unk) (View Amarel Review and Amarel Label ), LASIX (40 Mg, 2x/week) (View Lasix Review and Lasix Label ), DIFFU K (1 Df, 1x/day) (View Diffu K Review and Diffu K Label ), PREVISCAN (15 Mg, 1x/day) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6766182-1 | Arrhythmia, Hyperkalaemia, Renal Failure
Adverse event was reported on Jun 02, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: Unk) was diagnosed with hypertension, hyperthyroidism and. Location: FRANCE , 89 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), hyperkalaemia, renal failure. During the same period patient was treated with APROVEL (Unk) (View Aprovel Review and Aprovel Label ), LERCAN (Unk) (View Lercan Review and Lercan Label ), HYPERIUM (Unk) (View Hyperium Review and Hyperium Label ), NEO MERCAZOLE TAB (1 Df Per Day) (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ).

6766177-8 | Activated Partial Thromboplastin Time Prolonged, Haematocrit Decreased, Haemoglobin Decreased
on Jun 02, 2010 Female patient from FRANCE , 90 years of age, was diagnosed with cardiac failure, deep vein thrombosis (What is deep vein thrombosis?), myocardial ischaemia, hypothyroidism and was treated with Aldactone (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, haematocrit decreased, haemoglobin decreased. Aldactone dosage: 25 Mg, 2x/day. During the same period patient was treated with CALCIPARINE (5000 Iu, 2x/day) (View Calciparine Review and Calciparine Label ), KARDEGIC (75 Mg, 1x/day) (View Kardegic Review and Kardegic Label ), PREVISCAN (10 Mg, 1x/day) (View Previscan Review and Previscan Label ), LASIX (250 Mg, 1x/day) (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (75 A?g) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZYLORIC ^FAES^ (100 Mg) (View Zyloric ^faes^ Review and Zyloric ^faes^ Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ).

6763854-X | Chromaturia
on Jun 01, 2010 Male patient from JAPAN , 62 years of age, was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: chromaturia. Aldactone dosage: 50 Mbq, 1x/day.

6763821-6 | Chromaturia
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia on May 31, 2010 from JAPAN Additional patient health information: Female patient , child 3 years of age, was diagnosed with oedema and. Aldactone dosage: 50 Mg, Daily. During the same period patient was treated with LASIX (125 Mg, Daily) (View Lasix Review and Lasix Label ).

6763819-8 | Bladder Pain, Bladder Spasm, Calculus Urinary, Cystitis, Haematuria, Sleep Disorder
Adverse event was reported on May 31, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 12.5 Mg, 1x/day (half A 25 Mg Tablet Per Day)) was diagnosed with hypertension, hyperaldosteronism, asthma (What is asthma?) and. Location: FRANCE , 66 years of age, Patient had the following side effects: bladder pain, bladder spasm, calculus urinary, cystitis, haematuria, sleep disorder (What is sleep disorder?). During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), OROCAL VITAMIN D (View Orocal Vitamin D Review and Orocal Vitamin D Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), AIROMIR (View Airomir Review and Airomir Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6759240-9 | Decreased Appetite, Liver Function Test Abnormal, Oedema, Renal Function Test Abnormal
on May 26, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with oedema and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: decreased appetite, liver function test abnormal, oedema, renal function test abnormal. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6755714-5 | Blood Pressure Decreased, Cardiac Disorder, Dizziness, Malaise, Nausea
on May 24, 2010 Male patient from UNITED STATES , 81 years of age, weighting 170.0 lb, was diagnosed with cardiac disorder and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac disorder, dizziness (What is dizziness?), malaise, nausea (What is nausea?). Aldactone dosage: Unk. During the same period patient was treated with PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ), ACCUPRIL (20 Mg, Unk) (View Accupril Review and Accupril Label ), COREG (40 Mg, Unk) (View Coreg Review and Coreg Label ), ZOLOFT (100 Mg, Unk) (View Zoloft Review and Zoloft Label ), BUSPAR (15 Mg, 3x/day) (View Buspar Review and Buspar Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ), VITAMINS (Unk) (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

6755365-2 | Hyperkalaemia, Hyponatraemia, Somnolence
Patient was taking Aldactone (View Usage). Patient had the following side effects: hyperkalaemia, hyponatraemia, somnolence on May 24, 2010 from SPAIN Additional patient health information: Female patient , 85 years of age, was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?), prophylaxis and. Aldactone dosage: 100 Mg, 1x/day. During the same period patient was treated with ENALAPRIL MALEATE (5 Mg, 1x/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ), TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (3 Df, 1x/day) (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ), ADIRO (100 Mg, 1x/day) (View Adiro Review and Adiro Label ). Patient was hospitalized.

6755352-4 | Blood Glucose Increased
Adverse event was reported on May 24, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 25 Mg, Daily) was diagnosed with diabetes mellitus and. Location: JAPAN , 80 years of age, After Aldactone was administered, patient had the following side effects: blood glucose increased. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), GLUFAST (View Glufast Review and Glufast Label ).

6750229-2 | Polyuria
on May 21, 2010 Female patient from JAPAN , 79 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: polyuria. Aldactone dosage: 25 Mg Daily.

6749455-8 | Confusional State, Fall, Hyponatraemia
on May 17, 2010 Female patient from FRANCE , 87 years of age, was diagnosed with hypertension, dementia alzheimer's type, back pain (What is back pain?), depression (What is depression?), type 2 diabetes mellitus, osteoporosis (What is osteoporosis?) and was treated with Aldactone (View Usage). Patient had the following side effects: confusional state, fall (What is fall?), hyponatraemia. Aldactone dosage: 50 Mg, Daily. During the same period patient was treated with ARICEPT (10 Mg, Daily) (View Aricept Review and Aricept Label ), ACTISKENAN (10 Mg, 3x/day) (View Actiskenan Review and Actiskenan Label ), DURAGESIC 100 (1 Df, Every 3 Days) (View Duragesic-100 Review and Duragesic-100 Label ), DEROXAT (20 Mg, Daily) (View Deroxat Review and Deroxat Label ), NEXIUM (20 Mg, Daily) (View Nexium Review and Nexium Label ), DIAMICRON (30 Mg, Daily) (View Diamicron Review and Diamicron Label ), COVERSYL (4 Mg, Daily) (View Coversyl Review and Coversyl Label ), FOSAMAX (10 Mg, Weekly) (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6746352-9 | Hepatic Encephalopathy
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hepatic encephalopathy on May 19, 2010 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with oedema peripheral and. Aldactone dosage: Unk. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6746347-5 | Eosinophilia, Toxic Skin Eruption
Adverse event was reported on May 17, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: Unk) . Location: FRANCE , 52 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, toxic skin eruption. During the same period patient was treated with XELODA (Unk) (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6746333-5 | Confusional State, Fall, Hyponatraemia
on May 17, 2010 Female patient from FRANCE , 87 years of age, was diagnosed with hypertension, back pain (What is back pain?), dementia alzheimer's type, depression (What is depression?), type 2 diabetes mellitus, osteoporosis (What is osteoporosis?) and was treated with Aldactone (View Usage). Patient had the following side effects: confusional state, fall (What is fall?), hyponatraemia. Aldactone dosage: 50 Mg, Daily. During the same period patient was treated with ACTISKENAN (10 Mg, 3x/day) (View Actiskenan Review and Actiskenan Label ), ARICEPT (10 Mg, Daily) (View Aricept Review and Aricept Label ), DURAGESIC 100 (1 Df, Every 3 Days) (View Duragesic-100 Review and Duragesic-100 Label ), DEROXAT (20 Mg, Daily) (View Deroxat Review and Deroxat Label ), NEXIUM (20 Mg, Daily) (View Nexium Review and Nexium Label ), DIAMICRON (30 Mg, Daily) (View Diamicron Review and Diamicron Label ), COVERSYL (4 Mg, Daily) (View Coversyl Review and Coversyl Label ), FOSAMAX (10 Mg, Weekly) (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6741306-0 | Platelet Count Decreased, White Blood Cell Count Decreased
on May 14, 2010 Female patient from JAPAN , 57 years of age, weighting 123.5 lb, was diagnosed with pleural effusion, oedema and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: platelet count decreased, white blood cell count decreased. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (40 Mg, Daily) (View Lasix Review and Lasix Label ), AMINOLEBAN (Unk) (View Aminoleban Review and Aminoleban Label ), ALBUMIN HUMAN (Unk) (View Albumin Human Review and Albumin Human Label ).

6733623-5 | Liver Function Test Abnormal, Rheumatoid Arthritis
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal, rheumatoid arthritis (What is rheumatoid arthritis?) on Apr 19, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Aldactone dosage: . During the same period patient was treated with ETANERCEPT (Unk) (View Etanercept Review and Etanercept Label ), RHEUMATREX (4 Df, Daily) (View Rheumatrex Review and Rheumatrex Label ), LASIX (View Lasix Review and Lasix Label ).

6728619-3 | Hyperkalaemia, Renal Failure Acute
Adverse event was reported on May 06, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 50 Mg Daily) was diagnosed with hepatic cirrhosis, ascites and. Location: SPAIN , 46 years of age, Patient had the following side effects: hyperkalaemia, renal failure acute. During the same period patient was treated with METHADONE (50 Mg, 1x/day) (View Methadone Review and Methadone Label ), PROPRANOLOL (60 Mg, 1x/day) (View Propranolol Review and Propranolol Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ).

6727981-5 | Hepatic Encephalopathy, Renal Failure Acute
on May 06, 2010 Female patient from SPAIN , 73 years of age, was diagnosed with ascites, type 2 diabetes mellitus and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hepatic encephalopathy, renal failure acute. Aldactone dosage: 25 Mg, 4x/day. During the same period patient was treated with METFORMIN (2.55 G) (View Metformin Review and Metformin Label ), FUROSEMIDE (40 Mg, Daily) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6725566-8 | Renal Failure Acute
on May 04, 2010 Male patient from SPAIN , 74 years of age, was diagnosed with cardiac failure and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with ENALAPRIL (10 Mg, 1x/day) (View Enalapril Review and Enalapril Label ), DEFERASIROX (125 Mg, Unk) (View Deferasirox Review and Deferasirox Label ), HIDROSALURETIL (50 Mg, 1x/day) (View Hidrosaluretil Review and Hidrosaluretil Label ), SEGURIL (40 Mg, 2x/day) (View Seguril Review and Seguril Label ). Patient was hospitalized.

6703556-9 | Erythema, Pruritus, Skin Necrosis
Patient was taking Aldactone (View Usage). Patient had the following side effects: erythema, pruritus, skin necrosis on Apr 19, 2010 from SWITZERLAND Additional patient health information: Male patient , 70 years of age, weighting 297.6 lb, . Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (100 Mg, 1x/day) (View Lasix Review and Lasix Label ), TORSEMIDE (5 Mg, 1x/day) (View Torsemide Review and Torsemide Label ), KONAKION (5 Mg, Single) (View Konakion Review and Konakion Label ), LAXOBERON (15 Gtt, 1x/day) (View Laxoberon Review and Laxoberon Label ), LISINOPRIL (10 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6701614-6 | Palpitations, Paraesthesia, Tremor, Vertigo
Adverse event was reported on Apr 14, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 50 Mg,daily) was diagnosed with hypertension and. Location: FRANCE , 65 years of age, After Aldactone was administered, patient had the following side effects: palpitations, paraesthesia, tremor, vertigo. During the same period patient was treated with AMLOR (Unk) (View Amlor Review and Amlor Label ).

6700238-4 | Platelet Count Decreased, White Blood Cell Count Decreased
on Apr 16, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with oedema and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, white blood cell count decreased. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (40 Mg, Daily) (View Lasix Review and Lasix Label ), AMINOLEBAN (Unk) (View Aminoleban Review and Aminoleban Label ), ALBUMIN HUMAN (Unk) (View Albumin Human Review and Albumin Human Label ).

6694323-3 | Neuropathy Peripheral
on Apr 13, 2010 Male patient from JAPAN , 67 years of age, was treated with Aldactone (View Usage). Patient had the following side effects: neuropathy peripheral. Aldactone dosage: 50 Mg, Daily.

6694318-X | Eosinophilia, Erythema, Pruritus
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: eosinophilia, erythema, pruritus on Apr 13, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, weighting 141.1 lb, was diagnosed with oedema, delirium tremens, alcohol abuse, vitamin b1 deficiency, vitamin b6 deficiency, hepatitis alcoholic, infection (What is infection?) and. Aldactone dosage: 75 Mg, 1x/day. During the same period patient was treated with EQUANIL (400 Mg, 3x/day) (View Equanil Review and Equanil Label ), AOTAL (333 Mg, 3x/day) (View Aotal Review and Aotal Label ), VITAMIN B1 TAB (2 Df, 2x/day) (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ), VITAMIN B6 (2 Df, 2x/day) (View Vitamin B6 Review and Vitamin B6 Label ), TORENTAL (1200 Mg, 1x/day) (View Torental Review and Torental Label ), SOLUPRED (40 Mg, 1x/day) (View Solupred Review and Solupred Label ), AMOXICILLIN TRIHYDRATE (Unk) (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

6693962-3 | Hepatic Encephalopathy, Renal Failure
Adverse event was reported on Apr 13, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with cardiac failure congestive and. Location: SPAIN , 70 years of age, Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy, renal failure. During the same period patient was treated with SEGURIL (80 Mg, Daily) (View Seguril Review and Seguril Label ). Patient was hospitalized.

6690758-3 | Palpitations, Paraesthesia, Tremor, Vertigo
on Apr 12, 2010 Female patient from FRANCE , 65 years of age, was diagnosed with hypertension and was treated with Aldactone (View Usage). Patient had the following side effects: palpitations, paraesthesia, tremor, vertigo. Aldactone dosage: 50 Mg,daily. During the same period patient was treated with AMLOR (Unk) (View Amlor Review and Amlor Label ).

6680664-2 | Blood Sodium Decreased, Coma
on Apr 02, 2010 Female patient from UNITED STATES , 82 years of age, was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: blood sodium decreased, coma. Aldactone dosage: . Patient was hospitalized.

6674574-4 | Pemphigoid, Skin Lesion
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigoid, skin lesion on Mar 29, 2010 from FRANCE Additional patient health information: Male patient , 71 years of age, . Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg, 1x/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ), PREVISCAN (20 Mg, 1x/day) (View Previscan Review and Previscan Label ), GLICLAZIDE (1 Df, 1x/day) (View Gliclazide Review and Gliclazide Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), ESIDRIX (Unk) (View Esidrix Review and Esidrix Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6665809-2 | Neuropathy Peripheral
Adverse event was reported on Mar 25, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 50 Mg, Daily) . Location: JAPAN , 67 years of age, Patient had the following side effects: neuropathy peripheral.

6665391-X | Hepatic Encephalopathy
on Mar 24, 2010 Male patient from FRANCE , 78 years of age, was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hepatic encephalopathy. Aldactone dosage: 75 Mg, 1x/day. During the same period patient was treated with AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), NEXIUM (View Nexium Review and Nexium Label ), LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), NOROXIN (View Noroxin Review and Noroxin Label ). Patient was hospitalized.

6655558-9 | Benign Neoplasm Of Thyroid Gland
on Mar 17, 2010 Female patient from UNITED STATES , weighting 134.5 lb, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: benign neoplasm of thyroid gland. Aldactone dosage: 100 Mg, 2x/day.

6642748-4 | Erythema, Pruritus, Skin Necrosis
Patient was taking Aldactone (View Usage). Patient had the following side effects: erythema, pruritus, skin necrosis on Mar 09, 2010 from SWITZERLAND Additional patient health information: Male patient , 70 years of age, weighting 297.6 lb, . Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (100 Mg, 1x/day) (View Lasix Review and Lasix Label ), TORSEMIDE (5 Mg, 1x/day) (View Torsemide Review and Torsemide Label ), KONAKION (5 Mg, Single) (View Konakion Review and Konakion Label ), LAXOBERON (15 Gtt, 1x/day) (View Laxoberon Review and Laxoberon Label ), LISINOPRIL (10 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6638803-5 | Pemphigoid, Skin Lesion
Adverse event was reported on Mar 05, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 25 Mg, 1x/day) . Location: FRANCE , 71 years of age, After Aldactone was administered, patient had the following side effects: pemphigoid, skin lesion. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg, 1x/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ), PREVISCAN (20 Mg, 1x/day) (View Previscan Review and Previscan Label ), GLICLAZIDE (1 Df, 1x/day) (View Gliclazide Review and Gliclazide Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), ESIDRIX (Unk) (View Esidrix Review and Esidrix Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6638791-1 | Bradycardia, Confusional State, Diarrhoea, Hyperkalaemia, Hyponatraemia, Hypotension, Malaise, Renal Failure Acute
on Mar 05, 2010 Male patient from FRANCE , 70 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, confusional state, diarrhoea, hyperkalaemia, hyponatraemia, hypotension, malaise, renal failure acute. Aldactone dosage: 75 Mg, Unk. During the same period patient was treated with AVLOCARDYL (160 Mg, 1x/day) (View Avlocardyl Review and Avlocardyl Label ), ALDALIX (View Aldalix Review and Aldalix Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6582797-8 | Toxic Skin Eruption
on Feb 05, 2010 Female patient from FRANCE , 81 years of age, was diagnosed with oedema peripheral, hypertension and was treated with Aldactone (View Usage). Patient had the following side effects: toxic skin eruption. Aldactone dosage: 75 Mg, 1x/day. During the same period patient was treated with LASILIX (40 Mg, 1x/day) (View Lasilix Review and Lasilix Label ), TRIATEC (2.5 Mg, 1x/day) (View Triatec Review and Triatec Label ), LANTUS (View Lantus Review and Lantus Label ), PREVISCAN (View Previscan Review and Previscan Label ), DIFFU K (View Diffu K Review and Diffu K Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ). Patient was hospitalized.

6579953-1 | Blood Creatinine Increased
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: blood creatinine increased on Feb 03, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, . Aldactone dosage: 25 Mg, 1x/day.

6575480-6 | Bradycardia, Cyanosis, Dehydration, Renal Failure Acute
Adverse event was reported on Jan 28, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 25 Mg, 1x/day) . Location: FRANCE , 87 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, cyanosis, dehydration, renal failure acute. During the same period patient was treated with FUROSEMIDE (2 Df, Daily) (View Furosemide Review and Furosemide Label ), TRIMEBUTINE MALEATE (6 Df, Daily) (View Trimebutine Maleate Review and Trimebutine Maleate Label ), CARDENSIEL (1.25 Mg, 1x/day) (View Cardensiel Review and Cardensiel Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (1 Df, 1x/day) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), MEMANTINE (10 Mg, 1x/day) (View Memantine Review and Memantine Label ), DOMPERIDONE (3 Df, Daily) (View Domperidone Review and Domperidone Label ), FORLAX (Unk Df, Unk) (View Forlax Review and Forlax Label ), DIFFU K (6 Df, Daily) (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6571723-3 | Pancreatitis
on Jan 26, 2010 Male patient from JAPAN , 77 years of age, was treated with Aldactone (View Usage). Patient had the following side effects: pancreatitis. Aldactone dosage: Unk.

6566566-0 | Atrioventricular Block Complete, Cardiogenic Shock, Hyperkalaemia
on Jan 21, 2010 Female patient from SPAIN , 92 years of age, was diagnosed with hypertension, prophylaxis, cardiac failure, atrial fibrillation (What is atrial fibrillation?), dyslipidaemia and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: atrioventricular block complete, cardiogenic shock, hyperkalaemia. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with PARAPRES (16 Mg, 1x/day) (View Parapres Review and Parapres Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), SEGURIL (80 Mg, 1x/day) (View Seguril Review and Seguril Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ), ZOCOR (10 Mg, 1x/day) (View Zocor Review and Zocor Label ). Patient was hospitalized.

6566553-2 | Duodenal Ulcer Haemorrhage, Hyperkalaemia, Renal Failure Acute
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer haemorrhage, hyperkalaemia, renal failure acute on Jan 21, 2010 from SPAIN Additional patient health information: Female patient , 73 years of age, was diagnosed with cardiac failure congestive, arthralgia, prophylaxis, hyperuricaemia and. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with NAPROXEN AND NAPROXEN SODIUM (500 Mg, 3x/day) (View Naproxen And Naproxen Sodium Review and Naproxen And Naproxen Sodium Label ), AMERIDE (Unk) (View Ameride Review and Ameride Label ), ADIRO (100 Mg, 1x/day) (View Adiro Review and Adiro Label ), ENALAPRIL (20 Mg, 1x/day) (View Enalapril Review and Enalapril Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6566194-7 | Encephalopathy, Hyponatraemia
Adverse event was reported on Jan 21, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: Unk) was diagnosed with oedema, thrombosis prophylaxis, hypertension, prophylaxis against gastrointestinal ulcer, atrial fibrillation (What is atrial fibrillation?) and. Location: SPAIN , 75 years of age, Patient had the following side effects: encephalopathy, hyponatraemia. During the same period patient was treated with SEGURIL (40 Mg, 2x/day) (View Seguril Review and Seguril Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ), COROPRES (Unk) (View Coropres Review and Coropres Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6565950-9 | Hostility, Product Quality Issue
on Jan 29, 2010 Female patient from UNITED STATES , 40 years of age, weighting 230.0 lb, was diagnosed with hypertension and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hostility, product quality issue. Aldactone dosage: Don't Recall -- Usual 5-6 Months.

6564991-5 | Electrocardiogram Qt Prolonged
on Jan 20, 2010 Female patient from JAPAN , 60 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. Aldactone dosage: 25 Mg, Daily. During the same period patient was treated with LASIX (40 Mg, Daily) (View Lasix Review and Lasix Label ), KLARICID (200 Mg, 2x/day) (View Klaricid Review and Klaricid Label ), OLMETEC (10 Mg, Daily) (View Olmetec Review and Olmetec Label ), ARTIST (50 Mg, Daily) (View Artist Review and Artist Label ), URSO 250 (3 Df, Daily) (View Urso 250 Review and Urso 250 Label ).

6558731-3 | Pancreatitis
Patient was taking Aldactone (View Usage). Patient had the following side effects: pancreatitis on Jan 18, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, . Aldactone dosage: Unk.